A plaintiff, Vallarie F., individually and on behalf of Peggy F., has filed a product liability lawsuit against the manufacturers of Xarelto, Janssen Research & Development, LLC., and Johnson & Johnson Company.

According to the Xarelto lawsuit, Peggy F. alleges that she suffered purported internal bleeding as a direct result from taking Xarelto, a blood thinning medication. Internal bleeding is one of several dangerous Xarelto side effects.

The Xarelto lawsuit is filed in Louisiana federal court as part of a multidistrict litigation currently in progress against Janssen and its parent company Johnson & Johnson, Bayer Healthcare Pharmaceuticals, and other related companies.

Peggy is a resident of the state of Texas and was there prescribed Xarelto. According to the dangerous Xarelto side effects lawsuit, however, the plaintiff “experienced a life-threatening, irreversible bleed and other severe injuries for the use of Xarelto, as well as severe pain and suffering…”

Dangerous Xarelto Side Effects Lawsuit Facts

Xarelto is a relatively new type of blood thinning medication prescribed to patients who are at risk of developing blood clots for a multitude of different reasons. And, although some patients have taken Xarelto without suffering dangerous Xarelto side effects, others have not been so lucky.

The anticoagulant was approved by the U.S. Food and Drug Administration to prevent heart attacks and strokes in patients who have been diagnosed with atrial fibrillation, a kind of abnormal heart rhythm.

It is also taken to prevent patients from developing deep vein thrombosis and pulmonary embolism. Deep vein thrombosis is the event in which a blood clot forms in the body’s deep vein, which typically is found in the legs. A pulmonary embolism occurs when a blood clot circulates and blockades one or more arteries in the lungs.

Xarelto may also be prescribed to patients who are undergoing extensive and major procedures such as a knee replacement surgery or hip replacement surgery, for example.

The Xarelto side effects lawsuit contends, however, that there were flaws in the manufacturers’ conduct of clinical trials to receive clearance by the U.S. Food and Drug Administration. The Xarelto side effects lawsuit states that the results of the clinical studies that were conducted were not properly represented and accurately marketed to the public, patients, and medical community at large.

One such study was the ROCKET AF clinical trial. According to the Xarelto side effects lawsuit, the clinical study illustrated that Xarelto was “non-inferior to warfarin for the prevention of stroke or systemic embolism in patients with non-valvular atrial fibrillation, with a similar risk of major bleeding.”

However, according to the Xarelto side effect lawsuit, “bleeding from gastrointestinal sites, including upper, lower, and rectal sites, occurred more frequently in the rivaroxaban group, as did bleeding that led to a drop in the hemoglobin level or bleeding that require transfusion.”

The Dangerous Xarelto Side Effect Lawsuit is Case No. 2:17-cv-09384-EEF-MBN and is part of the Xarelto MDL, In re: Xarelto (Rivaroxaban) Products Liability Litigation, MDL No 2592, in the U.S. District Court for the Eastern District of Louisiana.